Hollander David
- SEC CIK
- 0001793796
No open-market purchases or sales filed in the past year.
Current role at each company
- MANE Veradermics, IncChief R&D Officeras of Sep 3, 2026
- KPRX Kiora Pharmaceuticals IncDirectoras of Jun 12, 2026
- RVNC Revance Therapeutics, Inc.CMO & Global Therapeutics Leadas of Feb 6, 2025
- AERI Aerie Pharmaceuticals IncChief R&D Officeras of Feb 8, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hollander David as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RVNC Revance Therapeutics, Inc.
CMO & Global Therapeutics Lead1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2024 (view filing) | Nov 18 | 1 day | Hollander DavidCMO & Global Therapeutics Lead | SSale | −3.91K | $4.17 | −$16.3K | −3.6%104.9K after |